{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T18:18:59Z","timestamp":1791137939987,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000097","name":"National Center for Research Resources","doi-asserted-by":"publisher","award":["P20RR016454"],"award-info":[{"award-number":["P20RR016454"]}],"id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.2353\/ajpath.2007.061232","type":"journal-article","created":{"date-parts":[[2007,4,24]],"date-time":"2007-04-24T14:43:18Z","timestamp":1177425798000},"page":"1725-1738","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":219,"title":["Calpain-Cleavage of \u03b1-Synuclein"],"prefix":"10.1016","volume":"170","author":[{"given":"Brian M.","family":"Dufty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa R.","family":"Warner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng T.","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan X.","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Gomez-Isla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen M.","family":"Leenhouts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia T.","family":"Oxford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mel B.","family":"Feany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliezer","family":"Masliah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Troy T.","family":"Rohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.2353\/ajpath.2007.061232_bib1","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"10.2353\/ajpath.2007.061232_bib2","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1212\/WNL.47.5.1113","article-title":"Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop","volume":"47","author":"McKeith","year":"1996","journal-title":"Neurology"},{"key":"10.2353\/ajpath.2007.061232_bib3","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.1087753","article-title":"Molecular pathways of neurodegeneration in Parkinson's disease","volume":"302","author":"Dawson","year":"2003","journal-title":"Science"},{"key":"10.2353\/ajpath.2007.061232_bib4","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1365-2990.1986.tb00136.x","article-title":"Idiopathic Parkinson's disease and the Lewy body disorders","volume":"12","author":"Gibb","year":"1986","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"Suppl 1","key":"10.2353\/ajpath.2007.061232_bib5","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1002\/1099-1166(200112)16:1+<::AID-GPS562>3.0.CO;2-3","article-title":"Dementia with Lewy bodies: diagnosis and management","volume":"16","author":"Barber","year":"2001","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.2353\/ajpath.2007.061232_bib6","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/00019052-200108000-00001","article-title":"Alpha-synuclein and the Lewy body disorders","volume":"14","author":"Dickson","year":"2001","journal-title":"Curr Opin Neurol"},{"key":"10.2353\/ajpath.2007.061232_bib7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.molbrainres.2004.09.001","article-title":"Pathogenic effects of alpha-synuclein aggregation","volume":"134","author":"Lundvig","year":"2005","journal-title":"Brain Res Mol Brain Res"},{"key":"10.2353\/ajpath.2007.061232_bib8","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev.biochem.74.082803.133400","article-title":"The biochemistry of Parkinson's disease","volume":"74","author":"Cookson","year":"2005","journal-title":"Annu Rev Biochem"},{"key":"10.2353\/ajpath.2007.061232_bib9","doi-asserted-by":"crossref","first-page":"8968","DOI":"10.1073\/pnas.132197599","article-title":"Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 \u2192 Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice","volume":"99","author":"Lee","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.2353\/ajpath.2007.061232_bib10","first-page":"879","article-title":"Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies","volume":"152","author":"Baba","year":"1998","journal-title":"Am J Pathol"},{"key":"10.2353\/ajpath.2007.061232_bib11","doi-asserted-by":"crossref","first-page":"22670","DOI":"10.1074\/jbc.M501508200","article-title":"A precipitating role for truncated alpha-synuclein and the proteasome in alpha-synuclein aggregation: implications for pathogenesis of Parkinson's disease","volume":"280","author":"Liu","year":"2005","journal-title":"J Biol Chem"},{"key":"10.2353\/ajpath.2007.061232_bib12","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1073\/pnas.0406976102","article-title":"Aggregation promoting C-terminal truncation of alpha-synuclein is a normal cellular process and is enhanced by the familial Parkinson's disease-linked mutations","volume":"102","author":"Li","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.2353\/ajpath.2007.061232_bib13","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0896-6273(02)00682-7","article-title":"Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein","volume":"34","author":"Giasson","year":"2002","journal-title":"Neuron"},{"key":"10.2353\/ajpath.2007.061232_bib14","doi-asserted-by":"crossref","first-page":"4897","DOI":"10.1073\/pnas.97.9.4897","article-title":"Fiber diffraction of synthetic alpha-synuclein filaments shows amyloid-like cross-beta conformation","volume":"97","author":"Serpell","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.2353\/ajpath.2007.061232_bib15","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0306-4522(00)00077-4","article-title":"Enhanced vulnerability to oxidative stress by alpha-synuclein mutations and C-terminal truncation","volume":"97","author":"Kanda","year":"2000","journal-title":"Neuroscience"},{"key":"10.2353\/ajpath.2007.061232_bib16","doi-asserted-by":"crossref","first-page":"3942","DOI":"10.1523\/JNEUROSCI.4965-05.2006","article-title":"Pathological changes in dopaminergic nerve cells of the substantia nigra and olfactory bulb in mice transgenic for truncated human alpha-synuclein(1\u2013120): implications for Lewy body disorders","volume":"26","author":"Tofaris","year":"2006","journal-title":"J Neurosci"},{"key":"10.2353\/ajpath.2007.061232_bib17","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1365-2613.2000.00169.x","article-title":"The pathogenic activation of calpain: a marker and mediator of cellular toxicity and disease states","volume":"81","author":"Vanderklish","year":"2000","journal-title":"Int J Exp Pathol"},{"key":"10.2353\/ajpath.2007.061232_bib18","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0962-8924(01)02179-1","article-title":"Cutting to the chase: calpain proteases in cell motility","volume":"12","author":"Glading","year":"2002","journal-title":"Trends Cell Biol"},{"key":"10.2353\/ajpath.2007.061232_bib19","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1046\/j.1471-4159.2003.01878.x","article-title":"Distinct cleavage patterns of normal and pathologic forms of alpha-synuclein by calpain I in vitro","volume":"86","author":"Mishizen-Eberz","year":"2003","journal-title":"J Neurochem"},{"key":"10.2353\/ajpath.2007.061232_bib20","doi-asserted-by":"crossref","first-page":"7818","DOI":"10.1021\/bi047846q","article-title":"Cleavage of alpha-Synuclein by calpain: potential role in degradation of fibrillized and nitrated species of alpha-synuclein","volume":"44","author":"Mishizen-Eberz","year":"2005","journal-title":"Biochemistry"},{"key":"10.2353\/ajpath.2007.061232_bib21","doi-asserted-by":"crossref","first-page":"8530","DOI":"10.1021\/bi027363r","article-title":"Role of alpha-synuclein carboxy-terminus on fibril formation in vitro","volume":"42","author":"Murray","year":"2003","journal-title":"Biochemistry"},{"key":"10.2353\/ajpath.2007.061232_bib22","doi-asserted-by":"crossref","first-page":"20775","DOI":"10.1074\/jbc.M313873200","article-title":"On the sequential determinants of calpain cleavage","volume":"279","author":"Tompa","year":"2004","journal-title":"J Biol Chem"},{"key":"10.2353\/ajpath.2007.061232_bib23","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1358\/dnp.2002.15.9.740233","article-title":"Caspase activation in the Alzheimer's disease brain: tortuous and torturous","volume":"15","author":"Rohn","year":"2002","journal-title":"Drug News Perspect"},{"key":"10.2353\/ajpath.2007.061232_bib24","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1046\/j.1471-4159.2001.00503.x","article-title":"Ca(2+)-induced inhibition of apoptosis in human SH-SY5Y neuroblastoma cells: degradation of apoptotic protease activating factor-1 (APAF-1)","volume":"78","author":"Reimertz","year":"2001","journal-title":"J Neurochem"},{"key":"10.2353\/ajpath.2007.061232_bib25","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1523\/JNEUROSCI.4485-05.2006","article-title":"Calpain-cleaved collapsin response mediator protein-3 induces neuronal death after glutamate toxicity and cerebral ischemia","volume":"26","author":"Hou","year":"2006","journal-title":"J Neurosci"},{"key":"10.2353\/ajpath.2007.061232_bib26","doi-asserted-by":"crossref","first-page":"936","DOI":"10.2353\/ajpath.2006.050798","article-title":"Caspase-mediated cleavage of glial fibrillary acidic protein within degenerating astrocytes of the Alzheimer's disease brain","volume":"168","author":"Mouser","year":"2006","journal-title":"Am J Pathol"},{"key":"10.2353\/ajpath.2007.061232_bib27","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0197-4580(02)00091-X","article-title":"Motor dysfunction and gliosis with preserved dopaminergic markers in human alpha-synuclein A30P transgenic mice","volume":"24","author":"Gomez-Isla","year":"2003","journal-title":"Neurobiol Aging"},{"key":"10.2353\/ajpath.2007.061232_bib28","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1126\/science.287.5456.1265","article-title":"Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders","volume":"287","author":"Masliah","year":"2000","journal-title":"Science"},{"key":"10.2353\/ajpath.2007.061232_bib29","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/jnr.10231","article-title":"Differential neuropathological alterations in transgenic mice expressing alpha-synuclein from the platelet-derived growth factor and Thy-1 promoters","volume":"68","author":"Rockenstein","year":"2002","journal-title":"J Neurosci Res"},{"key":"10.2353\/ajpath.2007.061232_bib30","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/35006074","article-title":"A Drosophila model of Parkinson's disease","volume":"404","author":"Feany","year":"2000","journal-title":"Nature"},{"key":"10.2353\/ajpath.2007.061232_bib31","doi-asserted-by":"crossref","first-page":"13782","DOI":"10.1021\/bi026284c","article-title":"Structural and functional implications of C-terminal regions of alpha-synuclein","volume":"41","author":"Kim","year":"2002","journal-title":"Biochemistry"},{"key":"10.2353\/ajpath.2007.061232_bib32","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1126\/science.1542796","article-title":"Age-associated inclusions in normal and transgenic mouse brain","volume":"255","author":"Jucker","year":"1992","journal-title":"Science"},{"key":"10.2353\/ajpath.2007.061232_bib33","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1046\/j.1471-4159.2001.00021.x","article-title":"The solubility of alpha-synuclein in multiple system atrophy differs from that of dementia with Lewy bodies and Parkinson's disease","volume":"76","author":"Campbell","year":"2001","journal-title":"J Neurochem"},{"key":"10.2353\/ajpath.2007.061232_bib34","doi-asserted-by":"crossref","first-page":"33855","DOI":"10.1074\/jbc.274.48.33855","article-title":"Degradation of alpha-synuclein by proteasome","volume":"274","author":"Bennett","year":"1999","journal-title":"J Biol Chem"},{"key":"10.2353\/ajpath.2007.061232_bib35","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0304-3940(00)01049-1","article-title":"Alpha-synuclein and the Parkinson's disease-related mutant Ala53Thr-alpha-synuclein do not undergo proteasomal degradation in HEK293 and neuronal cells","volume":"285","author":"Ancolio","year":"2000","journal-title":"Neurosci Lett"},{"key":"10.2353\/ajpath.2007.061232_bib36","doi-asserted-by":"crossref","first-page":"8053","DOI":"10.1523\/JNEUROSCI.21-20-08053.2001","article-title":"Induction of alpha-synuclein aggregation by intracellular nitrative insult","volume":"21","author":"Paxinou","year":"2001","journal-title":"J Neurosci"},{"key":"10.2353\/ajpath.2007.061232_bib37","doi-asserted-by":"crossref","first-page":"41890","DOI":"10.1074\/jbc.M306017200","article-title":"Parkin cleaves intracellular alpha-synuclein inclusions via the activation of calpain","volume":"278","author":"Kim","year":"2003","journal-title":"J Biol Chem"},{"key":"10.2353\/ajpath.2007.061232_bib38","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/35086067","article-title":"Failure of the ubiquitin-proteasome system in Parkinson's disease","volume":"2","author":"McNaught","year":"2001","journal-title":"Nat Rev Neurosci"},{"key":"10.2353\/ajpath.2007.061232_bib39","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0304-3940(00)01701-8","article-title":"Proteasomal function is impaired in substantia nigra in Parkinson's disease","volume":"297","author":"McNaught","year":"2001","journal-title":"Neurosci Lett"},{"key":"10.2353\/ajpath.2007.061232_bib40","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1006\/exnr.2002.8050","article-title":"Altered proteasomal function in sporadic Parkinson's disease","volume":"179","author":"McNaught","year":"2003","journal-title":"Exp Neurol"},{"key":"10.2353\/ajpath.2007.061232_bib41","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1212\/01.wnl.0000198511.09968.b3","article-title":"Peripheral proteasome and caspase activity in Parkinson disease and Alzheimer disease","volume":"66","author":"Blandini","year":"2006","journal-title":"Neurology"},{"key":"10.2353\/ajpath.2007.061232_bib42","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00401-005-1027-3","article-title":"Caspase-cleaved tau accumulation in neurodegenerative diseases associated with tau and alpha-synuclein pathology","volume":"110","author":"Newman","year":"2005","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.2353\/ajpath.2007.061232_bib43","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1073\/pnas.040556597","article-title":"Caspase-3: a vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease","volume":"97","author":"Hartmann","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.2353\/ajpath.2007.061232_bib44","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/0306-4522(96)00100-5","article-title":"Increased M-calpain expression in the mesencephalon of patients with Parkinson's disease but not in other neurodegenerative disorders involving the mesencephalon: a role in nerve cell death?","volume":"73","author":"Mouatt-Prigent","year":"1996","journal-title":"Neuroscience"},{"key":"10.2353\/ajpath.2007.061232_bib45","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1749-6632.2000.tb05202.x","article-title":"Calpain upregulation in spinal cords of mice with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinson's disease","volume":"914","author":"Ray","year":"2000","journal-title":"Ann NY Acad Sci"},{"key":"10.2353\/ajpath.2007.061232_bib46","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1023\/A:1007631826160","article-title":"Increased calpain expression is associated with apoptosis in rat spinal cord injury: calpain inhibitor provides neuroprotection","volume":"25","author":"Ray","year":"2000","journal-title":"Neurochem Res"},{"key":"10.2353\/ajpath.2007.061232_bib47","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1523\/JNEUROSCI.23-10-04081.2003","article-title":"Inhibition of calpains prevents neuronal and behavioral deficits in an MPTP mouse model of Parkinson's disease","volume":"23","author":"Crocker","year":"2003","journal-title":"J Neurosci"},{"key":"10.2353\/ajpath.2007.061232_bib48","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/ncb748","article-title":"Alpha-synuclein is phosphorylated in synucleinopathy lesions","volume":"4","author":"Fujiwara","year":"2002","journal-title":"Nat Cell Biol"},{"key":"10.2353\/ajpath.2007.061232_bib49","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/nn1443","article-title":"Alpha-synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease","volume":"8","author":"Chen","year":"2005","journal-title":"Nat Neurosci"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944010613843?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944010613843?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T14:07:47Z","timestamp":1757599667000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944010613843"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["S0002944010613843"],"URL":"https:\/\/doi.org\/10.2353\/ajpath.2007.061232","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Calpain-Cleavage of \u03b1-Synuclein","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.2353\/ajpath.2007.061232","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}